G1 Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of G1 Therapeutics generated cash of -$38,337,000, which is more than the previous year. Cash used in financing activities reached the amount of -$26,912,000 last year. Net change in cash is therefore -$62,376,000.
Cash Flow
| 2014 | -6.49M | -103.08K | 6.27M |
|---|---|---|---|
| 2015 | -13.84M | -87K | 33.17M |
| 2016 | -25.14M | -249.74K | 49.75M |
| 2017 | -50.51M | -294K | 107.32M |
| 2018 | -74.30M | -709K | 340.49M |
| 2019 | -99.57M | -2.71M | 2.70M |
| 2020 | -83.74M | 152K | 21.68M |
| 2021 | -132.10M | 0 | 145.86M |
| 2022 | -128.62M | -50.52M | 52.49M |
| 2023 | -38.33M | 2.81M | -26.91M |
GTHX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 94.65M | 221.56M | 207.80M | 269.70M | 369.29M | 103.81M | 47.30M | 22.93M | 3.69M | 0 |
Operating activities | ||||||||||
Net income | -47.96M | -147.55M | -148.35M | -99.25M | -122.44M | -85.28M | -60.12M | -30.29M | -20.26M | -6.67M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 513K | 530K | 469K | 582K | 356K | 175K | 89K | 67.22K | 42K | 17.31K |
Stock-based compensation expense | 14.51M | 20.58M | 22.31M | 18.77M | 16.44M | 0 | 3.39M | 1.39M | 389K | 73.58K |
| Deferred income tax benefit | 14.51M | 20.58M | 22.31M | 18.77M | 16.44M | 0 | 3.39M | 1.39M | 389K | 73.58K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.59M | -5.40M | -5.45M | -237K | 0 | 0 | 0 | 0 | 0 | 205.26K |
Inventories | 3.73M | -12.70M | -3.47M | -3.83M | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3.37M | 4.42M | -675K | -244K | 248K | -1.00M | 6.32M | 0 | 0 | 0 |
Cash generated by operating activities | -38.33M | -128.62M | -132.10M | -83.74M | -99.57M | -74.30M | -50.51M | -25.14M | -13.84M | -6.49M |
Investing activities | ||||||||||
Purchases Of Investments | -124.69M | -65.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -506K | 0 | 0 | -2.71M | -709K | -294K | -249.74K | -87K | -103.08K |
Acquisitions Net | 0 | 50.02M | 0 | 152K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 2.81M | -50.52M | 0 | 152K | -2.71M | -709K | -294K | -249.74K | -87K | -103.08K |
Financing activities | ||||||||||
Common Stock Issued | -224K | 52.38M | 92.22M | 2.30M | 2.70M | 0 | 108.50M | 0 | 33.31M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -139.45K | 0 |
Repayments of term debt | -26.68M | 0 | -55M | -19.38M | 0 | 0 | 0 | 0 | 0 | -49.47K |
Cash used in financing activities | -26.91M | 52.49M | 145.86M | 21.68M | 2.70M | 340.49M | 107.32M | 49.75M | 33.17M | 6.27M |
Net Change In Cash | -62.37M | -126.65M | 13.75M | -61.90M | -99.58M | 265.47M | 56.50M | 24.36M | 19.24M | 3.69M |
Cash at end of period | 32.28M | 94.90M | 221.56M | 207.80M | 269.70M | 369.29M | 103.81M | 47.30M | 22.93M | 3.69M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |